Behavioral Health Business September 11, 2024
Substance use disorder (SUD) treatment executives are largely optimistic that COVID-era telehealth prescribing flexibilities, set to expire in December 2024, will be made permanent.
But information released from a Drug Enforcement Administration (DEA) insider and published in Politico Pro in the days since SUD executives spoke with Addiction Treatment Business suggest an outcome different from what they originally hoped.
“We’re cautiously optimistic that DEA will develop a process through which patients are able to safely continue to receive telehealth care,” Gil Kochman, CEO of Workit Health, told ATB. “We’re also optimistic that DEA will finally fulfill its responsibility to create a special registration process that pre-approves providers like ours to safely prescribe addiction treatment medications via telehealth.”
Ann Arbor,...
Today's Sponsors
Today's Sponsor